Clinical Trial: Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia.
Brief Summary: This is a multi-centre survey of patients who are currently on lipid lowering pharmacological treatment in South Africa.
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome: Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III
- Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to the Fourth Joint European Task Force Guidelines/South African Guidelines in primary/secondary prevention patients, patients with metabolic syndrome
- Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III Guidelines
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: December 4, 2009
Date Started: November 2009
Date Completion:
Last Updated: April 14, 2011
Last Verified: April 2011